Cellectis (CLLS) Equity Ratio (2014 - 2026)

Cellectis' Equity Ratio history runs 13 years deep, the most recent figure standing at 0.21 for Q1 2026.

• In Q1 2026, Equity Ratio fell 35.08% year-over-year to 0.21; the TTM figure through Mar 2026 stood at 0.21 (down 35.08% YoY), while the FY2025 annual figure was 0.23, down 31.58% from the prior year.
• Equity Ratio was 0.21 for Q1 2026 at Cellectis, down from 0.23 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.58 in Q1 2022 to a low of 0.21 in Q1 2026.
• Historically, Equity Ratio has averaged 0.37 across 5 years, with a median of 0.34 in 2024.
• The sharpest annual moves came in 2023 and 2024: Equity Ratio tumbled 47.45% in 2023, then jumped 34.84% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.48 in 2022, then sank by 47.45% to 0.25 in 2023, then jumped by 34.84% to 0.34 in 2024, then plunged by 31.58% to 0.23 in 2025, then declined by 11.35% to 0.21 in 2026.
• The last three Equity Ratio figures came in at 0.21 (Q1 2026), 0.23 (Q4 2025), and 0.29 (Q3 2025), per Business Quant data.